THERAPEUTICS HOLDINGS INC.
35 Gatehouse Drive
October 9, 2020
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: James Young
|Re:||Entasis Therapeutics Holdings Inc.|
Registration Statement on Form S-3
Filed October 5, 2020
File No. 333-249315
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Entasis Therapeutics Holdings Inc. (the “Company”) hereby respectfully requests that the effective date for the registration statement referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern time, on October 13, 2020, or as soon as practicable thereafter.
Should you have any questions regarding the foregoing, please call the Company’s counsel, Brian K. Rosenzweig or Reid S. Hooper of Covington & Burling LLP, who can be reached at (202) 662-6000.
Thank you for your assistance in this matter.
|Very truly yours,|
|Entasis Therapeutics Holdings Inc..|
|By:||/s/ Elizabeth M. Keiley|
|Name:||Elizabeth M. Keiley|